Estrella Immunopharma, Inc. — All Filings
240 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-KT
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEF 14A
DEFA14A
EFFECT
NT 10-Q
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-24-065292 | Aug 6, 2024 | Jul 31, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-058085 | Jul 2, 2024 | Jun 26, 2024 |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-058547 | Jul 2, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-043642 | May 15, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-043126 | May 15, 2024 | Mar 31, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-042444 | May 13, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-031716 | Apr 10, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-021188 | Mar 11, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-021186 | Mar 11, 2024 | Mar 8, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-020566 | Mar 7, 2024 | Mar 4, 2024 |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-020772 | Mar 7, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-014668 | Feb 16, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-014191 | Feb 14, 2024 | Dec 31, 2023 |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-012668 | Feb 12, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-009325 | Feb 2, 2024 | Jan 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-007723 | Jan 30, 2024 | — |
| 424B3 | PROSPECTUS | 0001213900-23-099286 | Dec 28, 2023 | — |
| EFFECT | — | 9999999995-23-003778 | Dec 28, 2023 | — |
| CORRESP | — | 0001213900-23-099043 | Dec 27, 2023 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-23-096259 | Dec 18, 2023 | — |
| CORRESP | — | 0001213900-23-096260 | Dec 15, 2023 | — |
| UPLOAD | — | 0000000000-23-012758 | Nov 21, 2023 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-23-088827 | Nov 20, 2023 | Sep 30, 2023 |
| NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-23-087213 | Nov 15, 2023 | Sep 30, 2023 |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-23-087115 | Nov 14, 2023 | Sep 29, 2023 |
| S-1/A | REGISTRATION STATEMENT | 0001213900-23-086235 | Nov 13, 2023 | — |
| CORRESP | — | 0001213900-23-086238 | Nov 13, 2023 | — |
| SC 13D | SCHEDULE 13D | 0001013762-23-007392 | Oct 30, 2023 | — |
| UPLOAD | — | 0000000000-23-011589 | Oct 23, 2023 | — |
| S-1 | REGISTRATION STATEMENT | 0001013762-23-002940 | Oct 11, 2023 | — |
| 3 | — | 0001013762-23-002846 | Oct 10, 2023 | Sep 29, 2023 |
| 3 | — | 0001013762-23-002847 | Oct 10, 2023 | Sep 29, 2023 |
| 3 | — | 0001013762-23-002838 | Oct 10, 2023 | Sep 29, 2023 |
| 3 | — | 0001013762-23-002841 | Oct 10, 2023 | Sep 29, 2023 |
| 3 | — | 0001013762-23-002842 | Oct 10, 2023 | Sep 29, 2023 |
| 3 | — | 0001013762-23-002844 | Oct 10, 2023 | Sep 29, 2023 |
| 3 | — | 0001013762-23-002845 | Oct 10, 2023 | Sep 29, 2023 |
| 4 | — | 0000902664-23-005013 | Oct 5, 2023 | Sep 29, 2023 |
| 8-K | FORM 8-K | 0001013762-23-002216 | Oct 5, 2023 | Sep 29, 2023 |
| 25-NSE | — | 0001354457-23-000724 | Oct 5, 2023 | — |
| 4 | — | 0001013762-23-000415 | Oct 2, 2023 | Sep 29, 2023 |
| 4 | — | 0001013762-23-000416 | Oct 2, 2023 | Sep 29, 2023 |
| 4 | — | 0001013762-23-000417 | Oct 2, 2023 | Sep 29, 2023 |
| 4 | — | 0001013762-23-000421 | Oct 2, 2023 | Sep 29, 2023 |
| 4 | — | 0001013762-23-000420 | Oct 2, 2023 | Sep 29, 2023 |
| 4 | — | 0001013762-23-000418 | Oct 2, 2023 | Sep 29, 2023 |
| 4 | — | 0001013762-23-000419 | Oct 2, 2023 | Sep 29, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-077995 | Sep 20, 2023 | Sep 14, 2023 |
| 425 | CURRENT REPORT | 0001213900-23-077998 | Sep 20, 2023 | — |
| 425 | CURRENT REPORT | 0001213900-23-077395 | Sep 18, 2023 | — |